Drug Type Antibody |
Synonyms LIN 2007 |
Target |
Mechanism FcRn modulators(IgG receptor FcRn large subunit p51 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | CN | 17 Jul 2022 |